Leukocyte removal efficiency of cell-washed and unwashed whole blood: an in vitro study

Abstract

Leukocyte filtration of the cardiopulmonary bypass (CPB) perfusate after cardiac surgery has evolved as an important technique to prevent effector functions mediated by activated leukocytes. However, little is known about the filtration efficiency. Therefore, an in vitro study was conducted to define the leukocyte removal rate of a transfusion leukocyte-depletion filter, using cell-washed and unwashed whole porcine blood. In addition, the influence of different cell-washing protocols on the elimination rate of blood cells (leukocytes and platelets) was investigated.

Fresh, diluted, pooled, heparinized, porcine blood was processed using either a high-flow (HF, n-5) or quality-wash (QW, n-5) protocol on a continuous auto-transfusion system, or was left unprocessed (control n-5). Thereafter, all samples were filtered using a transfusion leukocyte-depletion filter. Blood samples for measurement of hematocrit, white blood cell count, including leukocyte differentiation and platelet count, were taken before and after filtration. To compare the experimental groups, the removal rate was presented as the fraction of leukocytes or platelets removed per plasma volume.

Cell washing significantly altered the fraction of leukocytes removed per plasma volume when compared to unprocessed blood (2.07 and 2.36 in the HF and QW groups, respectively, versus 1.34 in the control group, p-0.008 for both). No statistically significant difference in leukocyte removal rate was observed between the different cell-washing protocols. The leukocyte differential count showed that, during all experiments, the neutrophils were removed most efficiently (99.7%). Overall, significantly more platelets were depleted after cell washing compared to the control group (1.47 and 1.60 in the HF and QW groups, respectively, versus 1.12 in the control group, p-0.008 and 0.032, respectively). Furthermore, the amount of blood that could be filtered using a single pass technique did not significantly differ between the experimental groups. However, a larger variation in the total amount of filtered blood was observed in the unprocessed group (5709/398 mL) compared to the cell-washed groups (3609/42 and 4309/97 mL in the HF and QW groups, respectively).

In conclusion, blood processing with an auto-transfusion system significantly enhances the leukocyte and platelet removal efficiency of the transfusion leukocyte-depletion filter that was studied. In particular, neutrophils were efficiently removed.

Get full access to this article

View all access options for this article.

References

Bove JR.

Transfusion-associated hepatitis and AIDS. What is the risk?

N Engl J Med 1987; 317: 242-245 .

Wheatley T , Veitch P. Effect of blood transfusion on postoperative immunocompetence . Br J Anaesth 1997; 78: 489-492 .

Dodd RY. The risk of transfusion-transmitted infection . N Engl J Med 1992; 327: 419-421 .

Scott BH , Seifert FC , Glass PS , Grimson R. Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, haematocrit, gender, age, and body weight . Anesth Analg 2003; 97: 958-963 .

Cross M. Auto-transfusion in cardiac surgery . Perfusion 2001; 16: 391-400 .

Salas Millan J , De Vega N , Carmona Aurioles J et al. Auto-transfusion after cardiac surgery. Hematological, biochemical and immunological properties of shed mediastinal blood . Rev Esp Anesthesiol Reanim 2001; 48: 122-130 .

Stover EP , Siegel LC , Parks R et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group . Anesthesiology 1998; 88: 327-333 .

Liu B , Belboul A , Larsson S , Roberts D. Factors influencing haemostasis and blood transfusion in cardiac surgery . Perfusion 1996; 11: 131-143 .

Goodnough LT , Johnston MF , Toy PT. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group . JAMA 1991; 265: 86-90 .

10.

Spanier T , Tector K , Schwartz G et al. Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery . Perfusion 2000; 15: 427-431 .

11.

Aldea GS , Soltow LO , Chandler WL et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits . J Thorac Cardiovasc Surg 2002; 123: 742-755 .

12.

DeSomer F , van Belleghem Y , Caes F et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass . J Thorac Cardiovasc Surg 2002; 123: 951-958 .

13.

Weerwind PW , Lindhout T , Caberg NEH , de Jong DS. Thrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field . Thromb J 2003; 1: 3-3 .

14.

Martin J , Robitaille D , Perrault L et al. Reinfusion of mediastinal blood after heart surgery . J Thorac Cardiovasc Surg 2000; 120: 499-504 .

15.

Flom-Halvorsen H , Øvrum E , Tangen G , Brosstad F , Ringdal MA , Øystese R. Auto-transfusion in coronary bypass grafting: disparity in laboratory tests and clinical performance . J Thorac Cardiovasc Surg 1999; 118: 610-617 .

16.

Komiya T , Ban K , Yamazaki K , Date O , Nakamura T , Kanzaki Y. Blood conservation effect and safety of shed mediastinal blood auto-transfusion after cardiac surgery . Jpn J Thorac Cardiovasc Surg 1998; 46: 961-965 .

17.

De Haan J , Boonstra P , Monnink S , Ebels T , van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis . Ann Thorac Surg 1995; 59: 901-907 .

18.

Walpoth B , Eggensperger N , Walpoth-Aslan B et al. Qualitative assessment of blood washing with the continuous autologous transfusion system (CATS) . Int J Artif Organs 1997; 20: 234-239 .

19.

Booke M , Fobker M , Fingerhut D , Storm M , Mortle-mans Y , van Aken H. Fat elimination during intraoperative auto-transfusion: an in vitro investigation . Anaesth Analg 1997; 85: 959-962 .

20.

Male D. Introductie in het immuumsysteem. In Roitt I , Brostoff J , Male D eds. Immunologie, fourth edition. Houten/Diegem: Bohn Stafleu Van Loghum , 1996: 1.1-1.5.

21.

Silverthorn D. The immune system. In Silverthorn D ed. Human physiology, first edition. Upper Saddle River, NJ: Prentice-Hall , 1998: 654-669.

22.

Matheis G , Scholz M , Simon A , Dzemali O , Moritz A. Leukocyte filtration in cardiac surgery: a review . Perfusion 2001; 16: 361-370 .

23.

Morris H. Leukocyte reduction in cardiovascular surgery . Perfusion 2001; 16: 371-380 .

24.

Raife TJ. Adverse effects of transfusions caused by leucocytes . J Intraven Nurs 1997; 20: 238-244 .

25.

Wenz B , Gurtlinger B , O’Toole A , Dugan E. Preparation of granulocyte-poor red blood cells by micro-aggregate filtration: a simplified method to minimize febrile transfusion reactions . Vox Sang 1980; 39: 282-287 .

26.

Gott J , Cooper W , Schmidt F et al. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies . Ann Thorac Surg 1998; 66: 747-754 .

27.

Asimakopolous G , Taylor K. Effects of cardiopulmo-nary bypass on leukocyte and endothelial adhesion molecules . Ann Thorac Surg 1998; 66: 2135-2144 .

28.

Linden M. The hemostatic defect of cardiopulmo-nary bypass . J Thromb Thrombolysis 2003; 16: 129-147 .

29.

Warsaw D , Niewiarowska A , Theman T. Effect of auto-transfusion on fibrinolysis in open heart patients . J Extra Corpor Technol 2000; 32: 20-24 .

30.

Reents W , Babin-Ebell J , Misoph M , Schwarzkopf A , Elert O. Influence of different auto-transfusion devices on the quality of salvaged blood . Ann Thorac Surg 1999; 68: 58-62 .

31.

Perttilä J , Leino L , Pöyhönen M , Salo M. Leucocyte content in blood processed by auto-transfusion devices during open-heart surgery . Acta Anaesthesiol Scand 1995; 39: 445-448 .

32.

Walpoth BH , Egensperger N , Hauser S , Neidhart P , Kurt G , Althaus U. Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery . Int J Artif Organs 1999; 22: 210-216 .

33.

Heerdt E , Fransen E , Maessen J , de Jong D. Efficacy of leukocyte depletion of residual pump blood . Perfusion 2004; 19: 3-5 .

34.

Gu Y , de Vries A , Boonstra P , van Oeveren W. Clinical performance of a high-efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinized cardiopulmonary bypass perfusate . Perfusion 1995; 10: 425-430 .

35.

Gourlay T , Asimakopoulos G , Taylor KM. In Matheis G , Moritz A , Scholz M eds. Leukocyte depletion in cardiac surgery and cardiology. Basel (Switzerland): S. Karger , 2002: 1-12.

36.

Gessler P , Pfenninger J , Pfammatter J , Carrel T , Dahinden C. Inflammatory response of neutrophil granulocytes and monocytes after cardiopulmonary bypass in pediatric cardiac surgery . Intens Care Med 2002; 28: 1786-1791 .